Wanbury Ltd (WANBURY) — Board Meeting | 24 September 2026 (2 announcements)

24 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Board Meeting🟡 Notable Neutral📄 PDF

📢 Key Event

AGM approves cost auditor appointment and director re-appointment

🔄 What Changed

Ratified cost auditor remuneration and extended Whole-time Director tenure beyond 70 years

💡 Investor Takeaway

Shareholders retain continuity with existing leadership and auditor, supporting governance stability.

Wanbury Limited announced at its 38th Annual General Meeting on September 24, 2026, the appointment of ABK & Associates as cost auditor for FY 2026-27 and the re-appointment of Whole-time Director Mohan Kumar Rayana beyond age 70 until August 2031, with remuneration ratified.

2Board Meeting🟡 Notable Neutral📄 PDF

📢 Key Event

Wanbury's AGM approved FY2026 financials and reappointed directors.

🔄 What Changed

Ratified cost auditor remuneration and reappointed directors beyond retirement age.

🔮 What's Next

Voting results will be posted on the company website within 48 hours post-meeting.

💡 Investor Takeaway

Shareholders endorsed key governance and financial decisions, reinforcing board continuity.

Wanbury Ltd held its 38th AGM on September 24, 2026, approving audited FY2026 financials, reappointing directors K. Chandran and Mohan Kumar Rayana, and ratifying ABK & Associates as cost auditor. Shareholders accepted all resolutions via remote e-voting with a scrutinizer's report confirming majority approval. The meeting concluded at 12:35 PM after addressing member queries.

📊 Stock Analysis — WANBURY ✨ Ask AI About This

About Wanbury Ltd (WANBURY)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹775.48 CrP/E: 16.9ROE: 80.7%ROCE: 34.9%

View full WANBURY stock details →

📡 Get AI alerts when WANBURY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track WANBURY — Free

💡 Ask AI about this filing

"How does director re-appointment affect long-term strategy?""What is the cost auditor fee for FY 2026-27?""Will this change impact future dividend policy?"

Ask AI Free →

📊 More WANBURY filings

🔴 Annual Report — 31 August 2026Wanbury Ltd's 2025-26 Annual Report shows revenue of ₹65,120.54 lakhs and net profit of ₹6,613.47 la...
🔴 Annual Report — 31 August 2026Wanbury Ltd's 2025-26 Annual Report and 38th AGM notice highlight a 10.7% net profit of [amount cont...
🟡 Board Meeting — 31 August 2026Wanbury Ltd announced that its 38th Annual General Meeting will be held on 24 September 2026 via vid...
Announcement — 13 August 2026Wanbury Limited announced EDQM approval for Rivaroxaban API and USFDA DMF clearances for Paraxetine ...
🔴 Corporate Action — 11 August 2026Wanbury Limited announced the allotment of 27,530 equity shares to eligible employees who exercised ...

See all WANBURY filings →

🔥 Also filed on 24 September 2026

STEELXINDSteel Exchange India LtdAnnouncement 505343Monotype India LtdInsider Trading CARTRADECartrade Tech LtdAnnouncement BLBLIMITEDBLB LtdInsider Trading 530063Yashraj Containeurs LtdAnnouncement KPILKalpataru Projects International LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WANBURY files new disclosures

Track WANBURY filings, board meetings, and corporate actions. Free email alerts at 5 PM.